In conclusion, our findings highlight the role of the KLF1/Wnt/β‐catenin signaling pathway in cardiomyocyte proliferation and cardiac regeneration and suggest that the modulation of this pathway may be a potential therapeutic strategy for heart failure. This evidence concerns the gene KLF1 and heart failure.